AstraZeneca Vaccine is 62% and 90% Effective
AstraZeneca Vaccine is 62% and 90% Effective
More lectures on drbeen.com
Looking to support my educational work? Donate here:
https://paypal.me/mobeensyed?locale.x=en_US
AstraZeneca (Oxford college’s partner) has released the interim results for the trials conducting in the UK and Brazil.
https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html
Safety data study
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32466-1/fulltext
#koolbeens #drbeen #COVID19
Видео AstraZeneca Vaccine is 62% and 90% Effective канала Drbeen Medical Lectures
More lectures on drbeen.com
Looking to support my educational work? Donate here:
https://paypal.me/mobeensyed?locale.x=en_US
AstraZeneca (Oxford college’s partner) has released the interim results for the trials conducting in the UK and Brazil.
https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html
Safety data study
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32466-1/fulltext
#koolbeens #drbeen #COVID19
Видео AstraZeneca Vaccine is 62% and 90% Effective канала Drbeen Medical Lectures
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Preliminary COVID-19 Cytokine Storm Prediction Criteria
Metformin Reduces COVID-19 Mortality
Flurry of GREAT News, Pfizer, At-Home Test, Long-Lasting Immunity
Your COVID Questions Answered (Open Forum Friday November 13th)
Baricitinib Gets Emergency Use Authorization by FDA
Good News About BioNTech and Pfizer’s Vaccine
Good News Ivermectin Reduces Mortality In COVID-19 Patients
How SARS-COV-2 Disrupts Our Defense?
Introduction To P Values and Power
Aviptadil Works For SEVERE COVID-19 Patients
Study - Antibody Immunity to SARS-COV-2 Lasts And Matures At 6 Months
An Ivermectin Prophylaxis Study From India
Your COVID-19 Questions Answered (Open Forum 6th November 2020)
Cloth Masks Do Not Cause Hypoxia